| EVOTEC SE INH O.N. |
| Deutschland |
| Gesundheit |
| DE0005664809 / 566480 |
| EVT (Frankfurt) |
| FRA:EVT, ETR:EVT, EVT:GR |
| https://www.evotec.com/ |
|
Evotec SE is a leading life science company specializing in drug discovery and development for pharmaceutical and biotechnology partners. Founded in 1993 in Hamburg, Germany, it operates through two key segments: EVT Execute, which delivers integrate..
>Volltext.. |
| 498.57 Mio. EUR |
| 508.84 Mio. EUR |
| 719.12 Mio. EUR |
| -36.08 Mio. EUR |
| -197.55 Mio. EUR |
| -1.11 EUR |
| 477.09 Mio. EUR |
| 349.25 Mio. EUR |
| -113.21 Mio. EUR |
| 1.49 |
| -7.72% |
| -26.7% |
| - |
| - |
| - |
| - |
| EVOTEC |
| 29.09.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|